Impact of pharmaceutical care for asthma patients on health-related outcomes: An umbrella review

Ref ID 1046
First Author O. Montero Perez
Journal PHARMACOLOGY RESEARCH & PERSPECTIVES
Year Of Publishing 2024
URL https://bpspubs.onlinelibrary.wiley.com/doi/10.1002/prp2.1195
Keywords • Low methodological quality
• General medical
• Pharmacological
• Protocols
Problem(s) • Reasons for excluding potentially eligible studies not provided
• Conflicts of interest or funding of included studies not assessed
• Low methodological (AMSTAR) quality
• No registered or published protocol
Number of systematic reviews included 9
Summary of Findings From 9 systematic reviews indexed across PubMed, Embase, Scopus, and Cochrane Library from inception to December 2022. Of the nine systematic reviews included, six were judged critically low quality using AMSTAR 2. Only 2 of the reviews (22.2%) provided a list of excluded studies or reported on the sources of funding for the studies included in the review. Three reviews (33.3%) did not report a protocol or performed study selection in duplicate.
Did the article find that the problem(s) led to qualitative changes in interpretation of the results? N/A
Are the methods of the article described in enough detail to replicate the study?